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Summary The range of specificity of the CFU-S proliferation inhibitor and stimulator which are produced
endogenously in the bone marrow has been investigated by measuring their effects on the proportion of cells
killed by tritiated thymidine in mixed colony- (CFC-mix), erythroid burst- (BFU-E) and granulocyte/
macrophage colony- (GM-CFC) forming cells as well as spleen colony forming units (CFU-S). Both
CFU-S and CFC-mix were triggered by the stimulator into DNA-synthesis but BFU-E and GM-CFC were
unaffected. The range of activity of the inhibitor was confined solely to the CFU-S population. This defined
the specificity of both inhibitor and stimulator for the multipotent cells. The differential sensitivity of CFU-S
and CFC-mix to the inhibitor and the lack of it for the stimulator suggested (a) that the CFC-mix is a
relatively mature subpopulation of the CFU-S compartment and (b) that the relative sensitivity of a CFU-S
to these factors changes as it matures from the early stem cell stage (Inhibitor-sensitive) to the more mature
stages (Stimulator-sensitive) before becoming committed to a specific line of differentiation. The specificity of
the inhibitor for haemopoietic stem cells suggests its potential value during chemotherapeutic procedures.
The proliferative status of haemopoietic stem cells
measured as spleen colony-forming units or CFU-S
(Till & McCulloch, 1961) can be regulated by
endogenously derived inhibitory (Lord et al., 1976;
Frindel & Guigon, 1977; Cork et al., 1981) and
stimulatory (Frindel et al., 1976; Lord et al., 1977)
factors. In 1972 Gidali & Lajtha, studying the
kinetics of CFU-S behaviour following partial body
irradiation came to the conclusion that the
proliferation of CFU-S is regulated at a local level
rather than by circulating factors. Retrospectively,
the same conclusion was drawn from the work of
Rencricca et al., (1970) who demonstrated different
levels of CFU-S proliferation in bone marrow and
spleen. Since the factors we have described are
obtained from fresh, viable marrow - the inhibitor
from normal adult marrow in which CFU-S are
proliferatively quiescent; the stimulator from post-
irradiation marrow in which CFU-S are rapidly
proliferating - we consider them probably to be at
least a part of this local regulatory system. The
inhibitor, described by Frindel & Guigon is
obtained from other haemopoietic sources. It
probably has a lower mol. wt and is interpreted by
them to act humorally. The relationship between
these two factors, if any, is, therefore, unclear and
it should be pointed out that the data presented in
this paper refer only to the inhibitor described by
Lord et al., (1976), and Cork et al., (1981).
Whether this is also true for the stimulatory factor
is not known. Consequently, the properties
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described below cannot necessarily be extended to
the factors described by Frindel and her colleagues.
Nevertheless, like the inhibitor described by Frindel
& Guigon (1977) our material is at least relatively
specific to the CFU-S population in that it has no
effect on GM-CFC (granulocyte/macrophage
colony-forming cells, in vitro) (Lord et al, 1976).
Similarly, Cork et al., (1982) found that the
stimulator would not trigger proliferatively
suppressed GM-CFC back into cycle.
The in vitro colony techniques have now been
expanded for assaying other early committed
progenitor cells, e.g., the erythroid burst-forming
unit (BFU-E) and the mixed colony forming cell
(CFC-mix). This latter cell type is particularly
important since its growth in vitro produces a wide
range of recognisable blood-cell lines and
consequently it is considered to be a very close
temporal relative of the pluripotent CFU-S
population, if not the same cell. Its absolute
relationship to the CFU-S, however, is not known.
It has a sedimentation velocity similar to that of
the CFU-S (Johnson, 1980) and because of its
multipotency, it is almost certainly more primitive
than the BFU-E. On the other hand, its self
renewal capacity is less than that of the CFU-S
(Metcalf et al., 1979) though this could be an
artefact of the in vitro technique. There is a
tendency therefore to think of the CFC-mix as an
intermediary between the CFU-S and the BFU-E.
Measurements of the proliferative behaviour of
CFC-mix, in parallel with the BFU-E, GM-CFC
and CFU-S, have thus been used to examine more
fully the specificity of the endogenously produced
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inhibitor and stimulator for CFU-S proliferation,
to define the extent of their activities amongst the
haemopoietic progenitor cells and to investigate
further the temporal relationship of CFC-mix to
CFU-S and BFU-E.
Materials & methods
Bone marrow cells from male BDF1
(C57B19 x DBA2c) mice aged 8 to 10 weeks or
liver from DBA2 foetuses aged approximately 14d
were assayed for BFU-E, GM-CFC, CFC-mix and
CFU-S. The proportion of cells in DNA-synthesis
for each of these cell types was measured by the
tritiated thymidine (3HTdR) suicide technique
(Becker et al., 1965; Lord et al., 1974). Inhibitor
was obtained as a partially purified extract from
normal bone marrow cells, NBME-IV (Lord et al.,
1976). Fresh murine bone marrow was suspended
in saline at - 107cellsml- I and maintained at room
temperature for about 2h before removing the cells
by centrifugation. The cell free supernatant was
then fractionated on Amicon Diaflo membranes
and fraction IV, the 50-100 K dalton fraction,
retained as the inhibitor. Stimulator (RBME-III)
was similarly prepared as fraction III (the 30-50K
dalton Amicon fraction) from marrow regenerating
after a dose of 4.5Gy y-rays (Lord et al., 1977).
The preparations were stored freeze dried until
required.
BFU-E assay
BFU-E colonies (bursts) were assayed by culturing
2 x 105 marrow cells from BDF1 mice in cx-medium
supplemented with 0.9% methylcellulose, 15%
foetal calf serum, FCS (Gibco), 5% horse serum
(Flow), 10% w/v bovine serum albumin, BSA
(Sigma), 2uml 1 erythropoietin (Connaught, Step
III), 10-4M oc-thioglycerol, 10-7M sodium
succinate and 10-3M L-glutamine. Irradiated
(16Gy) bone marrow cells (106ml-1 of culture)
were added as a source of burst-promoting activity,
BPA. The cultures were incubated at 370C in a
fully humidified atmosphere of 5% CO2 in air and
the erythroid bursts were scored after 7-8 days
under an inverted microscope at 50 or 78 x
magnification. They were colonies composed solely
of erythroid cells, recognised by their size,
haemoglobinisation and characteristic arrangement
in tight clusters ofmulticentric bursts.
GM-CFC assay
GM-CFC colonies were assayed by culturing 105
marrow cells from BDF1 mice in 5cm plastic petri
dishes containing Fischer's medium with 25% horse
serum and 0.3% agar. Heart cell conditioned
medium was added (15%) as a source of colony
stimulating activity, CSA. Triplicate cultures were
incubated at 37°C in a humidified atmosphere
containing 5% CO2 in air. Colonies (>50 cells)
were counted after 7d of culture. They have the
typical loose spherical cellular arrangement of
granulocyte and/or macrophage colonies.
CFC-mix and BFU-E assays
In later experiments, mixed colony cultures were
established using Iscove's medium (Gibco Europe
Ltd). Supplements to the medium were the same as
for the BFU-E assay above except that FCS was
increased to 20% and erythropoietin reduced to
1 uml- . WEHI conditioned medium (10%) was
used as a source of colony stimulating activity. Day
14 gestation foetal liver cells were plated at a final
concentration of 105ml-1, at 0.25ml per well in
triplicate wells (Costar) and incubated at 37°C in a
fully humidified atmosphere containing 5% CO2
and 5% 02 in nitrogen. As these conditions also
allowed optimum growth of BFU-E and GM-CFC,
all three types of colony were scored in the same
cultures at day 7. Mixed colonies always had an
erythroid component as described for bursts above.
In addition, macrophage and granulocytes in loose
arrangements could be recognised within the
colonies. Megakaryocytes recognisable by their size
and refringence could also be found. On several
occasions, single mixed colonies were picked from
the cultures and their composition was confirmed
by morphological examination of cytocentrifuge
preparations.
CFU-S assay
CFU-S were assayed by the spleen colony technique (Till & McCulloch, 1961). Recipient BDF1 mice (10
per group) were irradiated (13.5Gy, 60Co y-rays at
0.85Gy h-1; Lord et al., 1984) and injected i.v.
with 5 x 104 foetal liver or normal bone marrow
cells for the inhibitor or stimulator studies
respectively. Mice were killed 9 days later, their
spleens excised and fixed in Bouin's solution and
the colonies counted.
Effects ofinhibitor and stimulator on cell
proliferation (3HTdR suicide assay)
Stimulator Normal bone marrow or foetal liver
cells were incubated in paired tubes containing
5 x 106 cells in 1 ml Fischer's medium supplemented
with 20% horse serum. Zero to 40,ug stimulator
(RBME III) was added to each tube and the
incubation continued for 2h at 370C. 7.4MBq
3HTdR in 0.2ml medium (Sp. Act.
555GBq mmol 1) was added to one tube of each
pair and an equal volume of medium to the secondSTEM CELL REGULATORS 337
tube for the last 30min of incubation. The tubes
were then quickly placed in ice to prevent further
isotope incorporation. Finally, the cells were
washed twice in medium containing cold thymidine
(100 gmlP ) and assayed for their content of the
various progenitor cell types.
Inhibitor Inhibitor (NBME-IV) was assayed in a
similar manner to that for the stimulator. In this
case, foetal liver cells were incubated for 2h or 5h.
In either case, 3HTdR was added for the last
30min of incubation only. The dose of NBME-IV
used lay in the range of0 to 80,gml- .
Results
Stimulator The potential of the extract from
regenerating marrow to stimulate (or trigger)
proliferation in various classes of early
haemopoietic progenitor cells was assessed in two
series of experiments. Using a common suspension
of normal adult bone marrow cells, CFU-S, BFU-E
and GM-CFC were first tested independently. The
results are shown in Table I. The RBME-III caused
a small, though not dose-related, reduction in the
plating efficiency of GM-CFC but not in that of
BFU-E or on the seeding efficiency of CFU-S: the
number of colonies produced remained unchanged
over a wide dose range of RBME-III. The
proportion of CFU-S in DNA-synthesis (i.e., the
proportion killed by 3HTdR) was increased from
the non-significant level found in normal quiescent
bone marrow CFU-S (6.5%) to -30% (P<«0.001)
with a dose of 10 Igml-I or more. Although BFU-
E and GM-CFC are rapidly proliferating in normal
bone marrow their proliferation can be accelerated
by appropriate stimuli. For example, in irradiated
hypertransfused mice, the proportion of BFU-E in
DNA-synthesis is increased from 30 to 63%
(Iscove, 1977). Similarly, the proliferative index of
GM-CFC was increased from 35% in normal bone
marrow to 80% in regenerating bone marrow
(Iscove et al., 1970). However, the proliferation of
BFU-E and GM-CFC was not stimulated by
RBME-III doses up to 30Optgml-. It should be
noted that the marginal stimulation of GM-CFC
with 20,ugmlml was very small compared to that
for CFU-S (P=0.02 compared with P<0.001).
However, there was no indication of a dose
response (see below).
In the second series of experiments, foetal liver
CFC-mix, BFU-E and GM-CFC were assayed in a
single culture system. The results are shown in
Table II. In this system, the plating efficiencies of
all three cell types were unaffected by treatment
Table I Dose response of stimulator (RBME-III) on the proliferation of BFU-E,
GM-CFC and CFU-S derived from normal BDF1 bone marrow.
Colonies 10 5 BM cells % in DNA-S
-3HTdR +3HTdR (% killedby 3HTdR) pa
CFU-S
Control 20.8+2.0 19.4+0.8 6.5+9.7
5ig RBME-III 18.0+1.5 16.1+1.5 10.5+11.1 0.2
10ig 22.3+ 1.0 15.5+0.8 30.5+5.4 40.001
20pg 19.3+ 1.3 10.9+ 1.2 43.7+7.3 40.001
30Mg 20.2+1.6 14.9+1.7 26.3+10.4 <0.001
BFU-E
Control 14.8+2.3 9.2+ 1.3 37.9+ 13.1
5jg RBME-III 13.3+3.0 7.6+1.6 42.5+17.8 0.42
10pg 14.8+1.9 9.3+0.9 37.1+10.0 >0.9
20jg 19.3+2.7 12.0+0.3 37.9+8.8 0.85
30pg 14.2+ 1.2 8.7+0.7 38.8+7.1 0.75
GM-CFC
Control 212.6± 19.8 161.8+8.7 23.9+8.2
5,g RBME-III 161.0+10.1 110.9+6.2 31.1+5.8 0.19
10,tg 159.5+9.9 112.3+12.5 29.6+9.0 0.28
20,ug 163.0+7.6 102.0+10.4 37.4+7.0 0.023
30pg 165.8+9.8 125.9+8.9 24.1+7.0 0.82
Net 3-6 experiments at each dose.
Results shown ± standard error (results for % in S-phase are mean kills + sd
on the individual kills).
BM=normal bone marrow.
aP=significance ofdifference from control using a two-tailed x2 test.338 C. TEJERO et al,
Table II Dose response of stimulator (RBME-III) on the proliferation of CFC-
mix, BFU-E and CFC derived from 14d DBA2 foetal liver
Colonies 10 5FL cells % in DNA-S
3HTdR +3HTdR (% killed by 3HTdR) pa
CFC-mix
Control 14.8+ 1.3 11.0+0.9 25.7+8.9
5jug RBME-III 16.0+4.5 5.6+1.5 65.0+13.6 «0.001 lOjig 19.2+3.5 8.4+2.3 56.3+14.4 «0.001
20pg 14.3+2.7 6.3+1.7 56.0+14.5 40.001
30pg 18.4+1.8 7.2+1.0 60.9+6.6 40.001
BFU-E
Control 30.3+2.6 20.3+2.4 33.0+9.8
5pg RBME-III 33.3+ 10.4 20.6+7.6 38.2+ 14.1 0.37
10 lg 30.2+6.0 19.8+5.4 34.5+10.4 0.70
20pg 29.0+5.9 19.9+3.5 34.5+8.5 0.70
30pg 30.6+1.8 19.2+3.3 37.3+11.4 0.44
GM-CFC
Control 98.3+2.4 64.3+3.0 34.6+3.4
5,ug RBME-III 111.0+6.7 59.1 + 11.9 46.8+11.2 0.06
10pg nlo.3+7.6 69.0+4.9 37.4+6.2 0.57
20jg 98.5+6.0 61.5+7.9 37.6+8.9 >0.9
30,ug 93.5+8.4 66.0+10.9 29.4+13.3 0.52
Net 3-6 experiments at each dose
Results shown + standard error (results for % in S-phase are mean kills + sd
on the individual kills)
FL - foetal liver
ap significance ofdifference from control using a two-tailed x2 test.
with RBME-III. The 3HTdR suicide indices for
BFU-E and GM-CFC were again unchanged
(P=0.06 to >0.9). CFC-mix, however, were
triggered; the proportion killed by 3HTdR
increasing from 25.7% to the plateau level of
- 60% with as little as 5pg of the extract per ml
(P<0.001). The small stimulation of GM-CFC at
20pgml- 1 in the first series of experiments was not
confirmed in these experiments where no change in
proliferation was observed (P>0.9). Neither was
there any reduction in plating efficiency in these
experiments.
Inhibitor The inhibitor (NBME-IV) was assayed
against foetal liver CFC-mix, BFU-E and GM-CFC
in the combined culture technique and,
simultaneously, against CFU-S. The results are
shown in Table III. The plating and seeding
efficiencies of all cell types were largely unaffected
as was the 3HTdR suicide index of all but the
CFU-S. In this latter case, 20,jg NBME-IV per ml
of cells reduced the proportion killed by 3HTdR
from 31.5% to 10.1% after 5h incubation
(P<0.001). 40 igml-1 were required for inhibition
when the incubation period was 2h only (36.4% to
9.7%) (P<0.001). A marginal, but non-significant,
reduction in kill was seen in GM-CFC after 5h
incubation at 40jgml -1 (P=0.14).
In four of the fifteen sets of data for the in vitro
colony forming cells there was an apparent
stimulation of proliferation. These were, however,
non-systematic changes and small by comparison
with the highly significant inhibition of CFU-S
proliferation.
Discussion
The haemopoietic stem cell complex has recently
been described as a population with a well defined
age structure, the most primitive cells having a high
self-renewal and a low differentiation capacity while
the more mature cells have a lower self-renewal and
increased differentiation capacity (Schofield, 1978;
Rosendaal et al., 1979). This population of spleen
colony-forming units (CFU-S) gives rise to the
more restricted progenitor cells which separately
lead to the production of red blood cells (BFU-E),
granulocytes or macrophages (GM-CFC) etc. The
development of an in vitro assay system for
pluripotent cells indicated a CFC-mix which isSTEM CELL REGULATORS 339
Table III Dose response of inhibitor (NBME-IV) on the proliferation of BFU-E,
GM-CFC & CFU-S derived from DBA2 foetal liver
Colonies 10 5 FL cells % in DNA synthesis
- 3HTdR +3HTdR (% killed by 3HTdR) pa
2hrs CFC-mix
Control 14.3+3.6 9.8+4.2 31.3+6.4
20ug NBME-IV 12.0+5.7 6.8+3.9 43.2+4.4 0.06
40pg 11.0+3.5 7.0+0.9 36.3+9.4 0.37
80pg 13.0+4.4 9.4+2.5 28.0+3.0 0.72
5hrs
Control 10.0+4.6 5.6+2.1 44.0+23.5
20 9.3+1.5 4.5+3.0 51.7+18.3 0.21
40 10.7+1.5 3.8+1.5 64.5+12.1 >0.002
2hrs BFU-E
Control 28.3 +6.4 16.1+4.4 42.3+4.7
20pg 20.7+8.4 7.6+3.4 63.3+3.9 0.002
40pg 24.0+9.2 10.1+ 1.9 58.0+4.9 0.017
80pg 25.7+9.6 13.4+5.1 48.0+5.3 0.32
5hrs
Control 24.7+9.8 15.8+5.6 36.0+7.9
20 20.0±6.4 15.3+4.0 23.5+1.5 0.076
40 16.3+3.5 7.7+2.2 52.7+ 1.5 0.012
2hrs GM-CFC
Control 71.0+22.2 48.1+13.4 32.3+6.8
20 55.0+12.5 34.5+7.9 37.3+6.1 0.37
40 60.7+14.8 39.2+10.5 35.5+9.8 0.52
80 68.3+14.3 47.9±13.0 29.8+7.8 0.80
5hrs
Control 43.0+ 16.6 25.2+ 11.0 41.3+4.5
20 40.0+10.9 21.5+4.6 46.3+8.8 0.39
40 45.3+15.2 35.0+7.0 29.8+7.3 0.12
2hrs CFU-S
Control 11.8+1.1 7.5+0.8 36.4+6.9
20 12.1+1.2 9.0+0.5 25.8+4.2 0.14
40 10.3+0.6 9.3+1.2 9.7+4.5 40.001
80 11.2+0.9 10.3+0.7 8.0±5.9 40.001
5hrs
Control 14.5+2.7 9.9+0.4 31.5+2.4
20 12.7+1.7 11.4+0.9 10.1+7.3 «0.001
40 12.2+1.9 11.9+1.3 1.0+6.4 40.001
Net 3-6 experiments at each dose
Results shown ± se (see Tables I & II).
FL - foetal liver
2h & Sh represents the duration of incubation of the assay cells with the
inhibitor, NBME-IV.
ap - significance ofdifference from control using a two-tailed x2 test.340 C. TEJERO et al.
pluripotent, has a degree of self renewal capacity
and therefore, is at least very close to the CFU-S.
RBME-III has been shown to stimulate normal
CFU-S but not GM-CFC whose proliferative
activity has been suppressed (Cork et al., 1982).
NBME-IV, on the other hand, inhibits regenerating
CFU-S but not proliferating GM-CFC (Lord et al.,
1976). These two factors have, therefore, been
taken as proliferation regulators which are active
specifically against the CFU-S population. These
observations have now been extended to include the
other major derivative of the CFU-S, the erythroid
progenitor cells. By including also the CFC-mix,
the extent of the specificity could be better defined.
These experiments confirmed the specificity of
both NBME-IV and RBME-III for the pluripotent
cell forms. The stimulator, however, was active
against both the CFU-S and the CFC-mix (Tables I
and II) while the inhibitor was active against the
CFU-S only (Table III). These observations are in
accord with a separate series of experiments
(Wright & Lord, in preparation) where it was found
that the more primitive (12d) CFU-S are relatively
more responsive to inhibitor while the maturer (7d)
CFU-S are relatively more responsive to stimulator.
Thus, the current observation that the stimulator's
range of activity extends to the CFC-mix further
suggests that this population arises at the more
mature end of the CFU-S population. The range of
activity of the inhibitor is probably restricted
specifically to the purely CFU-S compartment.
Once definable as a precursor committed to a
specific line of development, however, a cell is no
longer responsive to either of these stem cell
regulating factors. Figure 1 illustrates





CFU-S _ CEC-mix BFU-E
Figure 1 Diagram illustrating the changing sensitivity
of a CFU-S to inhibitor and stimulator as it progresses
from the early, primitive stem cell stage through to the
more mature CFC-mix and committed precursor cell
stages.
the stem and committed cell populations and their
relative sensitivities to inhibitor and stimulator. It is
interesting to note that GM-CFC demonstrate a
similar heterogeneity in response to simulation in
that a cell's sensitivity to colony stimulating activity
appears to be related to its clone size potential
(Francis et al., 1981).
The ability to protect haemopoietic stem cells
against the cytotoxic effects of S-phase specific
agents such as is illustrated by the specificity of this
inhibitor means that extra flexibility in the use of
such drugs for chemotherapy should be possible.
Preliminary experiments have illustrated its
effectiveness in vivo (Lord and Wright, 1982) in a
similar manner to that of the inhibitor described by
Frindel and Guigon (1977).
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